{"id":"W2057332288","doi":"10.1185/03007995.2013.837817","title":"Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Canadian Diabetes Association","keywords":"Medicine; Exenatide; Liraglutide; Metformin; Type 2 diabetes; Incretin; Hypoglycemia; Glucagon-like peptide 1 receptor; Diabetes mellitus; Internal medicine; Glycemic; Clinical trial; Pharmacology; Endocrinology; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01037869,0.0005496259,0.002566603,0.001916872,0.0002676754,0.002299071,0.0008871209,0.001952024,0.004703242],"category_scores_gemma":[0.02001963,0.0003734583,0.002676242,0.002720839,0.0004808334,0.001873226,0.0007608185,0.001238235,0.0004645608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008303018,"about_ca_system_score_gemma":0.002039426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009481536,"about_ca_topic_score_gemma":0.002088609,"domain_scores_codex":[0.9922868,0.003723643,0.001887915,0.0004728975,0.001404888,0.0002238371],"domain_scores_gemma":[0.9733678,0.01739605,0.00629513,0.0003410815,0.002020165,0.0005798878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04189081,0.002018832,0.02144255,0.3794395,0.006350277,0.001104285,0.0006167738,0.0003054489,0.003420841,0.0006461684,0.003737862,0.5390266],"study_design_scores_gemma":[0.04557507,0.06953117,0.1728469,0.4878211,0.05220609,0.006561751,0.00162751,0.0007529786,0.008810736,0.00230487,0.1516294,0.0003324842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04139042,0.952418,0.0003158126,0.001407605,0.0004806117,0.0004705866,0.0006184712,0.00001304763,0.002885387],"genre_scores_gemma":[0.3099321,0.680748,0.002457803,0.003389317,0.001387959,0.0007106353,0.000699102,0.00001363146,0.0006613028],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01037869,"threshold_uncertainty_score":0.05488843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2269259120738071,"score_gpt":0.4576717572343769,"score_spread":0.2307458451605697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}